J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI ‘JIN-A02’ at the upcoming 2022 World Conference on Lung Cancer in Vienna, Austria

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!